Recursion Pharmaceuticals
RXRX
#4101
Rank
S$3.00 B
Marketcap
$7.74
Share price
-4.80%
Change (1 day)
-15.65%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.27 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's total liabilities are S$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Recursion Pharmaceuticals - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.25 B-13.01%
2022-12-31S$0.28 B217%
2021-12-31S$91.12 M-86.36%
2020-12-31S$0.66 B119.51%
2019-12-31S$0.30 B